Related Experiment Videos
Enkephalin reduces quantal content at the frog neuromuscular junction
Nature
|February 3, 1983
Summary
Met-enkephalin, an opiate peptide, was found to reduce neurotransmitter release at the frog neuromuscular junction. This suggests Met-enkephalin may directly impact calcium channels in vertebrate neurons.
Area of Science:
- Neuroscience
- Neuropharmacology
- Molecular Biology
Background:
- Opiate peptides, such as Met-enkephalin, are known to modulate calcium (Ca2+)-dependent neuronal events.
- Previous observations suggested Met-enkephalin might directly interact with Ca2+ channels in vertebrate neurons.
Purpose of the Study:
- To investigate the effect of Met-enkephalin on Ca2+ channels in presynaptic terminals.
- To examine Met-enkephalin's influence on neurotransmitter release at the frog neuromuscular junction.
Main Methods:
- Electrophysiological recordings from frog cutaneous pectoris muscle.
- Assessment of acetylcholine (ACh) release in response to nerve stimulation.
- Analysis of quantal content of transmitter release.
Main Results:
- Met-enkephalin reversibly and specifically reduced the quantal content of transmitter release.
- The effect is likely mediated by an action on inward Ca2+ current at the presynaptic terminal.
Conclusions:
- Met-enkephalin modulates neurotransmitter release at the frog neuromuscular junction.
- This modulation is likely achieved through direct interaction with presynaptic Ca2+ channels.